With a Innovation Grant from the Canadian Cancer Society, a University of Saskatchewan research team will treat dogs with drug-resistant lymphoma to uncover the reasons for this resistance and to identify ways to reverse it. "The cancer we’re studying – lymphoma – is very similar to human non-Hodgkin lymphoma. It’s spontaneous and responds to drug therapy. The same therapies are used, and both the canine and human cancers develop similar drug resistance,” says study leader Dr Troy Harkness, a molecular geneticist and professor at the university. “Because dogs age faster than humans, their disease advances more quickly and we are able to observe results that much sooner.”
Read more here.
No comments:
Post a Comment